Endothelial progenitor cells (EPCs) in ageing and age-related diseases: How currently available treatment modalities affect EPC biology, atherosclerosis, and cardiovascular outcomes

Mechanisms of Ageing and Development

Volumn 159, Issue , 2016, Pages 49-62

  Altabas, Velimir ^a   Altabas, Karmela ^a   Kirigin, Lora ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Ageing; Atherosclerosis; Endothelial progenitor cells (EPCs); EPC focused treatment

Indexed keywords

ALISKIREN; ATORVASTATIN; ENALAPRIL; EZETIMIBE; GLICLAZIDE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN DETEMIR; INSULIN GLARGINE; IRBESARTAN; LOSARTAN; MEPIRODIPINE; METFORMIN; NIFEDIPINE; OLMESARTAN; PERINDOPRIL; PIOGLITAZONE; PITAVASTATIN; PRAVASTATIN; RAMIPRIL; ROSUVASTATIN; SIMVASTATIN; SITAGLIPTIN; TELMISARTAN; TRICHLORMETHIAZIDE; UNINDEXED DRUG; VALSARTAN; VARDENAFIL; VOGLIBOSE; ZOFENOPRIL;

AGING; ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CELL HOMING; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIAL PROGENITOR CELL; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; METABOLIC DISORDER; NONHUMAN; NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ANIMAL; BONE MARROW CELL; METABOLISM; PATHOLOGY; REGENERATION;

AGING; ANIMALS; ATHEROSCLEROSIS; BONE MARROW CELLS; ENDOTHELIAL PROGENITOR CELLS; HUMANS; REGENERATION;

EID: 84960971170     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.02.009     Document Type: Review

References (171)

1. ADVANCE Collaborative Group, Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., Marre, M., Cooper, M., Glasziou, P., Grobbee, D., Hamet, P., Harrap, S., Heller, S., Liu, L., Mancia, G., Mogensen, C.E., Pan, C., Poulter, N., Rodgers, A., Williams, B., Bompoint, S., de Galan, B.E., Joshi, R., Travert, F., Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358:24 (2008), 2560–2572.
2. Alsheikh-Ali, A.A., Kitsios, G.D., Balk, E.M., Lau, J., Ip, S., The vulnerable atherosclerotic plaque: scope of the literature. Ann. Intern. Med. 153:6 (2010), 387–395.
3. Altabas, V., Diabetes, endothelial dysfunction, and vascular repair: what should a diabetologist keep his eye on?. Int. J. Endocrinol., 2015.
4. Asahara, T., Kawamoto, A., Masuda, H., Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29:11 (2011), 1650–1655 Atherosclerosis, 238(2):159–164.
5. Avogaro, A., Albiero, M., Menegazzo, L., de Kreutzenberg, S., Fadini, G.P., Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34:Suppl. 2 (2011), S285–S290.
6. Bahlmann, F.H., de Groot, K., Mueller, O., Hertel, B., Haller, H., Fliser, D., Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 45:4 (2005), 526–529.
7. Bailey, C.J., Safety of antidiabetes medications: an update. Clin. Pharmacol. Ther. 98:2 (2015), 185–195.
8. Bajer, B., Vlcek, M., Galusova, A., Imrich, R., Penesova, A., Exercise associated hormonal signals as powerful determinants of an effective fat mass loss. Endocr. Regul. 49:3 (2015), 151–163.
9. Balistreri, C.R., Buffa, S., Pisano, C., Lio, D., Ruvolo, G., Mazzesi, G., Are endothelial progenitor cells the real solution for cardiovascular diseases? Focus on controversies and perspectives. Biomed. Res. Int., 2015(2015), 2015, 835934.
10. Bao, Q., Pan, J., Qi, H., Wang, L., Qian, H., Jiang, F., Shao, Z., Xu, F., Tao, Z., Ma, Q., Nelson, P., Hu, X., Agieng and age-related diseases-from endocrine therapy to target therapy. Mol. Cell. Endocrinol. 394:1–2 (2014), 115–118.
11. Baran, Ç., Durdu, S., Dalva, K., Zaim, Ç., Dogan, A., Ocakoglu, G., Gürman, G., Arslan, Ö., Akar, A.R., Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev. 8:3 (2012), 963–971.
12. Baraniak, P.R., McDevitt, T.C., Stem cell paracrine actions and tissue regeneration. Regen. Med. 5:1 (2010), 121–143.
13. Bellastella, G., Maiorino, M.I., Pivonello, R., Grasso, L.F., Galdiero, M., Sinisi, A.A., Colao, A., Giugliano, D., Esposito, K., Circulating endothelial progenitor cells in acromegaly. J. Endocrinol. Invest. 36:10 (2013), 825–830.
14. Bentzon, J.F., Otsuka, F., Virmani, R., Falk, E., Mechanisms of plaque formation and rupture. Circ. Res. 114:12 (2014), 1852–1866.
15. Besler, C., Doerries, C., Giannotti, G., Lüscher, T.F., Landmesser, U., Pharmacological approaches to improve endothelial repair mechanisms. Expert Rev. Cardiovasc. Ther. 6:8 (2008), 1071–1082.
16. Bruyndonckx, L., Hoymans, V.Y., De Guchtenaere, A., Van Helvoirt, M., Van Craenenbroeck, E.M., Frederix, G., Lemmens, K., Vissers, D.K., Vrints, C.J., Ramet, J., Conraads, V.M., Diet, exercise, and endothelial function in obese adolescents. Pediatrics 135:3 (2015), e653–e661.
17. Cacciatore, F., Bruzzese, G., Vitale, D.F., Liguori, A., de Nigris, F., Fiorito, C., Infante, T., Donatelli, F., Minucci, P.B., Ignarro, L.J., Effects of ACE inhibition on circulating endothelial progenitor cells vascular damage, and oxidative stress in hypertensive patients. Eur. J. Clin. Pharmacol. 67 (2011), 877–883.
18. Camargo, L.M., França, C.N., Izar, M.C., Bianco, H.T., Lins, L.S., Barbosa, S.P., Pinheiro, L.F., Fonseca, F.A., Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy. Braz. J. Med. Biol. Res. 47:5 (2014), 432–437.
19. Cangiano, E., Marchesini, J., Campo, G., Francolini, G., Fortini, C., Carrà, G., Miccoli, M., Ceconi, C., Tavazzi, L., Ferrari, R., ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes. Am. J. Cardiovasc. Drugs 11:3 (2011), 189–198.
20. Chao, T.H., Tseng, S.Y., Chen, I.C., Tsai, Y.S., Huang, Y.Y., Liu, P.Y., Ou, H.Y., Li, Y.H., Wu, H.L., Cho, C.L., Tsai, L.M., Chen, J.H., Cilostazol enhances mobilization and proliferation of endothelial progenitor cells and collateral formation by modifying vasculo-angiogenic biomarkers in peripheral arterial disease. Int. J. Cardiol. 172:2 (2014), e371–e374.
21. Chen, L.L., Liao, Y.F., Zeng, T.S., Yu, F., Li, H.Q., Feng, Y., Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients. Endocrine 38:2 (2011), 266–275.
22. Chen, L.L., Yu, F., Zeng, T.S., Liao, Y.F., Li, Y.M., Ding, H.C., Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes. Eur. J. Pharmacol. 659:2–3 (2011), 296–301.
23. Chen, W.R., Shen, X.Q., Zhang, Y., Chen, Y.D., Hu, S.Y., Qian, G., Wang, J., Yang, J.J., Wang, Z.F., Tian, F., Effects of liraglutide on left ventricular function in patients with non-ST-segment elevation myocardial infarction. Endocrine, 2015 (ahead of print).
24. Chiva-Blanch, G., Condines, X., Magraner, E., Roth, I., Valderas-Martínez, P., Arranz, S., Casas, R., Martínez-Huélamo, M., Vallverdú-Queralt, A., Quifer-Rada, P., Lamuela-Raventos, R.M., Estruch, R., The non-alcoholic fraction of beer increases stromal cell derived factor 1 and the number of circulating endothelial progenitor cells in high cardiovascular risk subjects: a randomized clinical trial. Atherosclerosis 233:2 (2014), 518–524.
25. Choi, W.G., Kim, S.H., Yoon, H.S., Lee, E.J., Kim, D.W., Impact of an endothelial progenitor cell capturing stent on coronary microvascular function: comparison with drug-eluting stents. Korean J. Intern. Med. 30:1 (2015), 42–48.
26. Coppolino, G., Buemi, A., Bolignano, D., Lacquaniti, A., La Spada, M., Stilo, F., De Caridi, G., Benedetto, F., Loddo, S., Buemi, M., Spinelli, F., Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. J. Surg. Res. 157:1 (2009), e129–e135.
27. Cubbon, R.M., Kahn, M.B., Wheatcroft, S.B., Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clin. Sci. (Lond.) 117:5 (2009), 173–190.
28. de Ciuceis, C., Pilu, A., Rizzoni, D., Porteri, E., Muiesan, M.L., Salvetti, M., Paini, A., Belotti, E., Zani, F., Boari, G.E., Effect of antihypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension. Blood Press. 20 (2011), 77–83.
29. de Donato, G., Gussoni, G., de Donato, G., Cao, P., Setacci, C., Pratesi, C., Mazzone, A., Ferrari, M., Veglia, F., Bonizzoni, E., Settembrini, P., Ebner, H., Martino, A., Palombo, D., Eur. J. Vasc. Endovasc. Surg. 34:2 (2007), 194–198.
30. Del Papa, N., Cortiana, M., Vitali, C., Silvestris, I., Maglione, W., Comina, D.P., Lucchi, T., Cortelezzi, A., Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis. J. Rheumatol. 35:7 (2008), 1323–1328.
31. Desouza, C.V., Hamel, F.G., Bidasee, K., O'Connell, K., Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 60:4 (2011), 1286–1294.
32. Devin, J.K., Vaughan, D.E., Blevins, L.S. Jr., Chen, Q., Covington, J., Verity, D.K., Young, P.P., Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults. Growth Horm. IGF Res. 18:3 (2008), 253–263.
33. Di Stefano, R., Barsotti, M.C., Melillo, E., Iorio, M., Santoni, T., Armani, C., Dell'omodarme, M., Ristori, C., De Caterina, R., Balbarini, A., The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia. Thromb. Haemost. 100:5 (2008), 871–877.
34. Di Stefano, R., Barsotti, M.C., Felice, F., Magera, A., Lekakis, J., Leone, A., Balbarini, A., Smoking and endothelial progenitor cells: a revision of literature. Curr. Pharm. Des. 16:23 (2010), 2559–2566.
35. Donndorf, P., Lube, L., Lux, C., Skorska, A., Steinhoff, G., Kraft, K., Mobilization of bone marrow-derived endothelial progenitor cells following finnish sauna: a pilot study. Forsch. Komplement. 22:4 (2015), 246–250.
36. Dyakova, E.Y., Kapilevich, L.V., Shylko, V.G., Popov, S.V., Anfinogenova, Y., Physical exercise associated with NO production: signaling pathways and significance in health and disease. Front. Cell Dev. Biol., 3, 2015, 19.
37. Dzau, V.J., Gnecchi, M., Pachori, A.S., Morello, F., Melo, L.G., Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 46:1 (2005), 7–18.
38. Eleuteri, E., Mezzani, A., Di Stefano, A., Vallese, D., Gnemmi, I., Delle Donne, L., Taddeo, A., Della Bella, S., Giannuzzi, P., Aerobic training and angiogenesis activation in patients with stable chronic heart failure: a preliminary report. Biomarkers 18:5 (2013), 418–424.
39. Erbs, S., Beck, E.B., Linke, A., Adams, V., Gielen, S., Kränkel, N., Möbius-Winkler, S., Höllriegel, R., Thiele, H., Hambrecht, R., High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling-results from a randomized double-blind, and placebo-controlled study. Int. J. Cardiol. 146 (2011), 56–63.
40. Esposito, K., Maiorino, M.I., Di Palo, C., Gicchino, M., Petrizzo, M., Bellastella, G., Saccomanno, F., Giugliano, D., Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes—a randomized controlled trial. Diabetes Obes. Metab. 13:5 (2011), 439–445.
41. Fadini, G.P., Boscaro, E., Albiero, M., Menegazzo, L., Frison, V., de Kreutzenberg, S., Agostini, C., Tiengo, A., Avogaro, A., The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care 33 (2010), 1607–1609.
42. Fadini, G.P., de Kreutzenberg, S.V., Mariano, V., Boscaro, E., Bertolini, F., Mancuso, P., Quarna, J., Marescotti, M., Agostini, C., Tiengo, A., Avogaro, A., Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. Diabetes Obes. Metab. 13:8 (2011), 718–725.
43. Fadini, G.P., Albiero, M., Vigili de Kreutzenberg, S., Boscaro, E., Cappellari, R., Marescotti, M., Poncina, N., Agostini, C., Avogaro, A., Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 6:4 (2013), 943–949.
44. Fadini, G.P., Dassie, F., Albiero, M., Boscaro, E., Albano, I., Martini, C., de Kreutzenberg, S.V., Agostini, C., Avogaro, A., Vettor, R., Maffei, P., Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. J. Clin. Endocrinol. Metab. 99:12 (2014), E2549–E2556.
45. Feig, J.E., Regression of atherosclerosis: insights from animal and clinical studies. Ann. Global Health 80:1 (2014), 13–23.
46. Fernández, J.M., Rosado-Álvarez, D., Da Silva Grigoletto, M.E., Rangel-Zúñiga, O.A., Landaeta-Díaz, L.L., Caballero-Villarraso, J., López-Miranda, J., Pérez-Jiménez, F., Fuentes-Jiménez, F., Moderate-to-high-intensity training and a hypocaloric Mediterranean diet enhance endothelial progenitor cells and fitness in subjects with the metabolic syndrome. Clin. Sci. (Lond.) 123:6 (2012), 361–373.
47. Ferrannini, E., Cushman, W.C., Diabetes and hypertension: the bad companions. Lancet 380:9841 (2012), 601–610.
48. Florian, M., Florianova, L., Hussain, S., Magder, S., Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis?. Endothelium 15:5–6 (2008), 265–275.
49. Foresta, C., Lana, A., Cabrelle, A., Ferigo, M., Caretta, N., Garolla, A., Palù, G., Ferlin, A., PDE-5 inhibitor, vardenafil, increases circulating progenitor cells in humans. Int. J. Impot. Res. 17:4 (2005), 377–380.
50. Foresta, C., Caretta, N., Lana, A., De Toni, L., Biagioli, A., Ferlin, A., Garolla, A., Reduced number of circulating endothelial progenitor cells in hypogonadal men. J. Clin. Endocrinol. Metab. 91:11 (2006), 4599–4602.
51. Foresta, C., Ferlin, A., De Toni, L., Lana, A., Vinanzi, C., Galan, A., Caretta, N., Circulating endothelial progenitor cells and endothelial function after chronic tadalafil treatment in subjects with erectile dysfunction. Int. J. Impot. Res. 18:5 (2006), 484–488.
52. Foresta, C., De Toni, L., Di Mambro, A., Garolla, A., Ferlin, A., Zuccarello, D., The PDE5 inhibitor sildenafil increases circulating endothelial progenitor cells and CXCR4 expression. J. Sex Med. 6:2 (2009), 369–372.
53. Fukada, S., Ma, Y., Uezumi, A., Adult stem cell and mesenchymal progenitor theories of aging. Front cell Dev Biol., 2, 2014, 10, 10.3389/fcell.2014.00010.
54. Fulle, S., Centurione, L., Mancinelli, R., Sancilio, S., Manzoli, F.A., Di Pietro, R., Stem cell ageing and apoptosis. Curr. Pharm. Des. 18:13 (2012), 1694–1717.
55. Girlovanu, M., Susman, S., Soritau, O., Rus-Ciuca, D., Melincovici, C., Constantin, A.M., Mihu, C.M., Stem cells—biological update and cell therapy progress. Clujul Med. 88:3 (2015), 265–271.
56. Goldsmith, T.C., Modern evolutionary mechanics theoiried and resolving the programmed/non-programmed aging controversy. Biochemistry (Mosc.) 79:10 (2014), 1049–1055.
57. Green, J.B., Bethel, M.A., Armstrong, P.W., Buse, J.B., Engel, S.S., Garg, J., Josse, R., Kaufman, K.D., Koglin, J., Korn, S., Lachin, J.M., McGuire, D.K., Pencina, M.J., Standl, E., Stein, P.P., Suryawanshi, S., Van de Werf, F., Peterson, E.D., Holman, R.R., TECOS Study Group, Effect of Sitagliptin on cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 373:3 (2015), 232–242.
58. Harman, D., Free radical theory of aging: an update: increasing the functional life span. Ann. N. Y. Acad. Sci. 1067 (2006), 10–21.
59. Haude, M., Lee, S.W., Worthley, S.G., Silber, S., Verheye, S., Erbs, S., Rosli, M.A., Botelho, R., Meredith, I., Sim, K.H., Stella, P.R., Tan, H.C., Whitbourn, R., Thambar, S., Abizaid, A., Koh, T.H., Den Heijer, P., Parise, H., Cristea, E., Maehara, A., Mehran, R., The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitorcell capture stent with a paclitaxel-eluting stent. JACC Cardiovasc. Interv. 6:4 (2013), 334–343.
60. Hayflick, L., Recent advances in the cell biology of aging. Mech. Ageing Dev. 14:1–2 (1980), 59–79.
61. Hayflick, L., Antecedents of cell aging research. Exp Gerontol. 24:5–6 (1989), 355–365.
62. Herrmann, M., Verrier, S., Alini, M., Strategies to stimulate mobilization and homing of endogenous stem and progenitor cells for bone tissue repair. Front. Bioeng. Biotechnol., 2(3), 2015, 79.
63. Hibbert, B., Ma, X., Pourdjabbar, A., Simard, T., Rayner, K., Sun, J., Chen, Y.X., Filion, L., O'Brien, E.R., Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries. PLoS One, 6(1), 2011, e16413.
64. Hibbert, B., Simard, T., Ramirez, F.D., Pourdjabbar, A., Raizman, J.E., Maze, R., Wilson, K.R., Hawken, S., OʼBrien, E.R., The effect of statins on circulating endothelial progenitor cells in humans: a systematic review. J. Cardiovasc. Pharmacol. 62:5 (2013), 491–496.
65. Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., Finkel, T., Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 (2003), 593–600.
66. Hiyama, E., Hiyama, K., Telomere and telomerase in stem cells. Br. J. Cancer 96:7 (2007), 1020–1024.
67. Hristov, M., Fach, C., Becker, C., Heussen, N., Liehn, E.A., Blindt, R., Hanrath, P., Weber, C., Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 192 (2007), 413–420.
68. Hsu, C.W., Glycemic control in critically ill patients. World J. Crit. Care Med. 1:February (1) (2012), 31–39, 10.5492/wjccm.v1.i1.31.
69. Huang, B., Cheng, Y., Xie, Q., Lin, G., Wu, Y., Feng, Y., Gao, J., Xu, D., Effect of 40 mg versus 10 mg of atorvastatin on oxidized low-density lipoprotein high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy. Clin. Cardiol. 35 (2012), 125–130.
70. Humpert, P.M., Djuric, Z., Zeuge, U., Oikonomou, D., Seregin, Y., Laine, K., Eckstein, V., Nawroth, P.P., Bierhaus, A., Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling?. Mol. Med. 14:5–6 (2008), 301–308.
71. Iwakura, A., Luedemann, C., Shastry, S., Hanley, A., Kearney, M., Aikawa, R., Isner, J.M., Asahara, T., Losordo, D.W., Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108 (2003), 3115–3121.
72. James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Dennison-Himmelfarb, C., Handler, J., Lackland, D.T., LeFevre, M.L., MacKenzie, T.D., Ogedegbe, O., Smith, S.C. Jr., Svetkey, L.P., Taler, S.J., Townsend, R.R., Wright, J.T. Jr., Narva, A.S., Ortiz, E., 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:5 (2014), 507–520.
73. Jin, K., Modern biological theories of aging. Aging Dis. 1:2 (2010), 72–74.
74. Kalogirou, M., Tsimihodimos, V., Elisaf, M., Pleiotropic effects of ezetimibe: do they really exist?. Eur. J. Pharmacol. 633:May (1–3) (2010), 62–70.
75. Keith, M., Kuliszewski, M.A., Liao, C., Peeva, V., Ahmed, M., Tran, S., Sorokin, K., Jenkins, D.J., Errett, L., Leong-Poi, H., A modified portfolio diet complements medical management to reduce cardiovascular risk factors in diabetic patients with coronary artery disease. Clin. Nutr., 2014 pii: S0261-5614(14)00174-5.
76. Kim, W., Jeong, M.H., Cho, S.H., Yun, J.H., Chae, H.J., Ahn, Y.K., Lee, M.C., Cheng, X., Kondo, T., Murohara, T., Kang, J.C., Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ. J. 70:8 (2006), 1052–1057.
77. Kim, S.A., Park, J.B., O'Rourke, M.P., Vasculopathy of aging and the revised cardiovascular continuum. Pulse (Basel) 3:2 (2015), 141–147.
78. Kobayashi, N., Fukushima, H., Takeshima, H., Koguchi, W., Mamada, Y., Hirata, H., Machida, Y., Suzuki, N., Yokotsuka, F., Tabei, K., Kobayashi, E., Fukuda, N., Ishimitsu, T., Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb. Am. J. Hypertens, 2010, 1007–1013.
79. Kolovou, G.D., Kolovou, V., Mavrogeni, S., We are ageing. Biomed. Res. Int., 2014, 2014, 808307.
80. La Vignera, S., Condorelli, R., Vicari, E., D'Agata, R., Calogero, A., Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy. Aging Male 14:3 (2011), 183–189.
81. Laufs, U., Urhausen, A., Werner, N., Scharhag, J., Heitz, A., Kissner, G., Böhm, M., Kindermann, W., Nickenig, G., Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur. J. Cardiovasc. Prev. Rehabil. 12:4 (2005), 407–414.
82. Lee, P.S., Poh, K.K., Endothelial progenitor cells in cardiovascular diseases. World J. Stem Cells 6:3 (2014), 355–366.
83. Leeper, N.J., Hunter, A.L., Cooke, J.P., Stem cell therapy for vascular regeneration: adult embryonic, and induced pluripotent stem cells. Circulation 122:5 (2010), 517–526.
84. Leone, A.M., Rutella, S., Giannico, M.B., Perfetti, M., Zaccone, V., Brugaletta, S., Garramone, B., Niccoli, G., Porto, I., Liuzzo, G., Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Int. J. Cardiol. 130 (2008), 457–462.
85. Li, D.-W., Liu, Z.-Q., Wei, J., Liu, Y., Hu, L.-S., Contribution of endothelial progenitor cells to neovascularization (review). Int. J. Mol. Med. 30:5 (2012), 1000–1006.
86. Li, W., Wang, H., Kuang, C.Y., Zhu, J.K., Yu, Y., Qin, Z.X., Liu, J., Huang, L., An essentialrole for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting theproliferation of endothelial progenitor cells in vitro?. Mol. Cell. Biochem. 363:1–2 (2012), 135–145.
87. Liao, Y.F., Chen, L.L., Zeng, T.S., Li, Y.M., Fan, Yu, Hu, L.J., Ling, Yue, Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes. Vasc. Med. 15:4 (2010), 279–285.
88. Liao, C.H., Wu, Y.N., Lin, F.Y., Tsai, W.K., Liu, S.P., Chiang, H.S., Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism. Andrology 1:4 (2013), 563–569.
89. Lincoff, A.M., Wolski, K., Nicholls, S.J., Nissen, S.E., Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298:September (10) (2007), 1180–1188.
90. Lins, L.C., França, C.N., Fonseca, F.A., Barbosa, S.P., Matos, L.N., Aguirre, A.C., Bianco, H.T., do Amaral, J.B., Izar, M.C., Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients. Cell Biochem. Biophys. 70:1 (2014), 687–696.
91. Lønborg, J., Vejlstrup, N., Kelbæk, H., Bøtker, H.E., Kim, W.Y., Mathiasen, A.B., Jørgensen, E., Helqvist, S., Saunamäki, K., Clemmensen, P., Holmvang, L., Thuesen, L., Krusell, L.R., Jensen, J.S., Køber, L., Treiman, M., Holst, J.J., Engstrøm, T., Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur. Heart J. 33:12 (2012), 1491–1499.
92. Lu, L., Zhou, J.Z., Wang, L., Zhang, T.X., Effects of Xuezhikang and pravastatin on circulating endothelial progenitor cells in patients with essential hypertension. Chin. J. Integr. Med. 15:4 (2009), 266–271.
93. Madonna, De Caterina, Circulating endothelial progenitor cells: do they live up to their name?. Vasc. Pharmacol. 67–69 (2015), 2–5.
94. Maida, Y., Masutomi, K., Telomerase reverse transcriptase moonlights. Therapeutic targets beyond telomerase. Cancer Sci., 2015, 10.1111/cas.12806.
95. Makino, H., Okada, S., Nagumo, A., Sugisawa, T., Miyamoto, Y., Kishimoto, I., Akie, T.K., Soma, T., Taguchi, A., Yoshimasa, Y., Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients. Diabetes Res. Clin. Pract. 81 (2008), 327–330.
96. Manfredini, F., Rigolin, G.M., Malagoni, A.M., Catizone, L., Mandini, S., Sofritti, O., Huang, P.H., Chen, Y.H., Tsai, H.Y., Chen, J.S., Wu, T.C., Lin, F.Y., Sata, M., Chen, J.W., Lin, S.J., Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler. Thromb. Vasc. Biol. 30:4 (2010), 869–877.
97. Mannarino, E., Pirro, M., Endothelial injury and repair: a novel theory for atherosclerosis. Angiology 59:2 Suppl (2008), 69S–72S.
98. Mano, R., Ishida, A., Ohya, Y., Todoriki, H., Takishita, S., Dietary intervention with Okinawan vegetables increased circulating endothelial progenitor cells in healthy young women. Atherosclerosis 204:2 (2009), 544–548.
99. Marin, C., Ramirez, R., Delgado-Lista, J., Yubero-Serrano, E.M., Perez-Martinez, P., Carracedo, J., Garcia-Rios, A., Rodriguez, F., Gutierrez-Mariscal, F.M., Gomez, P., Perez-Jimenez, F., Lopez-Miranda, J., Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium. Am. J. Clin. Nutr. 93:2 (2011), 267–274.
100. Mauro, E., Soffritti, S., Boari, B., Cuneo, A., Zamboni, P., Manfredini, R., Exercise training and endothelial progenitor cells in haemodialysis patients. J. Int. Med. Res. 37:2 (2009), 534–540.
101. Min, T.Q., Zhu, C.J., Xiang, W.X., Hui, Z.J., Peng, S.Y., Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 18:3 (2004), 203–209.
102. Möbius-Winkler, S., Linke, A., Adams, V., Schuler, G., Erbs, S., How to improve endothelial repair mechanisms: the lifestyle approach. Expert Rev. Cardiovasc. Ther. 8:4 (2010), 573–580.
103. Mund, J.A., Ingram, D.A., Yoder, M.C., Case, J., Endothelial progenitor cells and cardiovascular cell-based therapies. Cytotherapy 11:2 (2009), 103–113.
104. Muraleedharan, V., Marsh, H., Kapoor, D., Channer, K.S., Jones, T.H., Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur. J. Endocrinol. 169:6 (2013), 725–733.
105. Nakamura, K., Oe, H., Kihara, H., Shimada, K., Fukuda, S., Watanabe, K., Takagi, T., Yunoki, K., Miyoshi, T., Hirata, K., Yoshikawa, J., Ito, H., DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study. Cardiovasc. Diabetol., 13(1), 2014, 110.
106. Nomura, S., Dynamic role of microparticles in type 2 diabetes mellitus. Curr. Diabetes Rev. 5:4 (2009), 245–251.
107. Oikonomou, E., Siasos, G., Zaromitidou, M., Hatzis, G., Mourouzis, K., Chrysohoou, C., Zisimos, K., Mazaris, S., Tourikis, P., Athanasiou, D., Stefanadis, C., Papavassiliou, A.G., Tousoulis, D., Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients. Atherosclerosis 238:2 (2015), 159–164.
108. Ozüyaman, B., Ebner, P., Niesler, U., Ziemann, J., Kleinbongard, P., Jax, T., Gödecke, A., Kelm, M., Kalka, C., Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb. Haemost. 94:4 (2005), 770–772.
109. Paradisi, G., Bracaglia, M., Basile, F., Di'Ipolito, S., Di Nicuolo, F., Ianniello, F., Quagliozzi, L., Donati, L., Labianca, A., Di Cesare, C., Effect of pravastatin on endothelial function and endothelial progenitor cells in healthy postmenopausal women. Clin. Exp. Obstet. Gynecol. 39 (2012), 153–159.
110. Paul, S.K., Klein, K., Maggs, D., Best, J.H., The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study. Cardiovasc. Diabetol., 14(January), 2015, 10.
111. Pelliccia, F., Pasceri, V., Cianfrocca, C., Vitale, C., Speciale, G., Gaudio, C., Rosano, G.M., Mercuro, G., Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized double-blind, placebo-controlled study. Atherosclerosis 210 (2010), 510–515.
112. Peris, P., Atkinson, E.J., Gössl, M., Kane, T.L., McCready, L.K., Lerman, A., Khosla, S., McGregor, U.I., Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. Mayo Clin. Proc. 88:1 (2013), 46–55.
113. Pesaro, A.E., Serrano, C.V. Jr., Katz, M., Marti, L., Fernandes, J.L., Parra, P.R., Campos, A.H., Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells. J. Cardiovasc. Pharmacol. Ther. 18:5 (2013), 447–452.
114. Porto, I., Di Vito, L., De Maria, G.L., Dato, I., Tritarelli, A., Leone, A.M., Niccoli, G., Capogrossi, M.C., Biasucci, L.M., Crea, F., Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome. Am. J. Cardiol. 103:11 (2009), 1500–1505.
115. Povsic, T.J., Najjar, S.S., Prather, K., Zhou, J., Adams, S.D., Zavodni, K.L., Kelly, F., Melton, L.G., Hasselblad, V., Heitner, J.F., Raman, S.V., Barsness, G.W., Patel, M.R., Kim, R.J., Lakatta, E.G., Harrington, R.A., Rao, S.V., EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy. J. Thromb. Thrombolysis 36:4 (2013), 375–383.
116. Povsic, T.J., Sloane, R., Zhou, J., Pieper, C.F., Pearson, M.P., Peterson, E.D., Green, J.B., Cohen, H.J., Morey, M.C., Lower levels of circulating progenitor cells are associated with low physical function and performance in elderly men with impaired glucose tolerance: a pilot substudy from the VA Enhanced Fitness trial. J. Gerontol. A Biol. Sci. Med. Sci. 68:12 (2013), 1559–1566.
117. Powell, T.M., Paul, J.D., Hill, J.M., Thompson, M., Benjamin, M., Rodrigo, M., McCoy, J.P., Read, E.J., Khuu, H.M., Leitman, S.F., Finkel, T., Cannon, R.O. 3rd, Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 25:2 (2005), 296–301.
118. Quiskamp, N., Bruin, J.E., Kieffer, T.J., Differentiation of human pluripotent stem cells into β-cells: potential and challenges. Best Pract. Res. Clin. Endocrinol. Metab. 29:6 (2015), 833–847.
119. Rabelink, T.J., de Boer, H.C., de Koning, E.J., van Zonneveld, A.J., Endothelial progenitor cells: more than an inflammatory response?. Arterioscler. Thromb. Vasc. Biol. 24:5 (2004), 834–838.
120. Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., Nishigaki, I., The vascular endothelium and human diseases. Int. J. Biol. Sci. 9:10 (2013), 1057–1069.
121. Raptis, A.E., Markakis, K.P., Mazioti, M.C., Ikonomidis, I., Maratou, E.P., Vlahakos, D.V., Kotsifaki, E.E., Voumvourakis, A.N., Tsirogianni, A.G., Lambadiari, V.A., Lekakis, J.P., Raptis, S.A., Dimitriadis, G.D., Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension. Am. J. Hypertens 28:1 (2015), 22–29.
122. Regazzi, R., Rodriguez-Trejo, A., Jacovetti, C., Insulin secretion in health and disease: nutrients dictate the pace. Proc. Nutr. Soc. 75:1 (2016), 19–29.
123. Rehman, J., Li, J., Orschell, C.M., March, K.L., Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003), 1164–1169.
124. Rennert, R.C., Sorkin, M., Garg, R.K., Gurtner, G.C., Stem cell recruitment after injury: lessons for regenerative medicine. Regen. Med. 7:6 (2012), 833–850.
125. Rizvi, S., Raza, S.T., Mahdi, F., Telomere lenght variations in aging and age. related diseases. Curr. Aging Sci. 7:3 (2014), 161–167.
126. Saeed, H., Iqtedar, Stem cell function and maintenance–ends that matter: role of telomeres and telomerase. J. Biosci. 38:3 (2013), 641–649.
127. Sandri, M., Adams, V., Gielen, S., Linke, A., Lenk, K., Kränkel, N., Lenz, D., Erbs, S., Scheinert, D., Mohr, F.W., Schuler, G., Hambrecht, R., Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111:25 (2005), 3391–3399.
128. Santos, S., Oliveira, A., Lopes, C., Systematic review of saturated fatty acids on inflammation and circulating levels of adipokines. Nutr. Res. 33:9 (2013), 687–695.
129. Scacciatella, P., D'Amico, M., Pennone, M., Conrotto, F., Meliga, E., Usmiani, T., Meynet, I., Gunetti, M., Ferrero, I., Rustichelli, D., Fagioli, F., Marra, S., Effects of EPC capture stent and CD34+ mobilization in acute myocardial infarction. Minerva Cardioangiol. 61:April (2) (2013), 211–219.
130. Schier, R., El-Zein, R., Cortes, A., Liu, M., Collins, M., Rafat, N., Teschendorf, P., Wu, H.K., Heymach, J., Mehran, R., Riedel, B., Endothelial progenitor cell mobilization by preoperative exercise: a bone marrow response associated with postoperative outcome. Br. J. Anaesth. 113:4 (2014), 652–660.
131. Schroeter, M.R., Leifheit, M., Sudholt, P., Heida, N.M., Dellas, C., Rohm, I., Alves, F., Zientkowska, M., Rafail, S., Puls, M., Hasenfuss, G., Konstantinides, S., Schäfer, K., Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ. Res. 103:5 (2008), 536–544.
132. Shakoor, S.K., Aldibbiat, A., Ingoe, L.E., Campbell, S.C., Sibal, L., Shaw, J., Home, P.D., Razvi, S., Weaver, J.U., Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. J. Clin. Endocrinol. Metab. 95:1 (2010), 319–322.
133. Snijders, T., Nederveen, J.P., McKay, B.R., Joanisse, S., Verdijk, L.B., van Loon, L.J., Parise, G., Satellite cells in human skeletal muscle plasticity. Front. Physiol., 6, 2015, 283.
134. Sobrino, T., Blanco, M., Pérez-Mato, M., Rodríguez-Yáñez, M., Castillo, J., Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase. Eur. J. Neurol. 19:12 (2012), 1539–1546.
135. Sorrentino, S., Bahlmann, F.H., Besler, C., Muller, M., Schulz, S., Kirchhoff, N., Doerries, C., Horvath, T., Limbourg, A., Limbourg, F., Fliser, D., Haller, H., Drexler, H., Landmesser, U., Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus:restoration by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 116 (2007), 163–173.
136. Spadaccio, C., Pollari, F., Casacalenda, A., Alfano, G., Genovese, J., Covino, E., Chello, M., Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J. Cardiovasc. Pharmacol. 55 (2010), 30–38.
137. Spiel, A.O., Mayr, F.B., Leitner, J.M., Firbas, C., Sieghart, W., Jilma, B., Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. Thromb. Res. 123:1 (2008), 108–113.
138. Spigoni, V., Lombardi, C., Cito, M., Picconi, A., Ridolfi, V., Andreoli, R., Anelli, N., Gnudi, L., Goldoni, M., Zavaroni, I., Raddino, R., Dei Cas, A., N-3 PUFA increase bioavailability and function of endothelial progenitor cells. Food Funct. 5:8 (2014), 1881–1890.
139. Spinetti, G., Kraenkel, N., Emanueli, C., Madeddu, P., Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc. Res. 78:2 (2008), 265–273.
140. Sugiura, T., Kondo, T., Kureishi-Bando, Y., Numaguchi, Y., Yoshida, O., Dohi, Y., Kimura, G., Ueda, R., Rabelink, T.J., Murohara, T., Nifedipine improves endothelial function: role of endothelial progenitor cells. Hypertension 52 (2008), 491–498.
141. Sun, Z., Atherosclerosis and atheroma plaque rupture, normal anatomy of vasa vasorim and their role associated with atherosclerosis. Sci. World J., 2014 Article ID 285058.
142. Sun, J.Y., Zhai, L., Li, Q.L., Ye, J.X., Kang, L.N., Xie, J., Xu, B., Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients. Clinics (Sao Paulo) 68:5 (2013), 665–673.
143. Suzuki, G., Translational research of adult stem cell therapy. World J. Cardiol. 7:11 (2015), 707–718.
144. Suzuki, R., Fukuda, N., Katakawa, M., Tsunemi, A., Tahira, Y., Matsumoto, T., Ueno, T., Soma, M., Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension. Am. J. Hypertens 27:5 (2014), 695–701.
145. Tan, H., Li, X., Chen, W., Chen, Y., Wei, X., Yang, Y., Zhang, H., Jin, Q., Effects of losartan on the mobilization of endothelial progenitor cells and improvement of endothelial function. Ann. Clin. Lab. Sci. 43:4 (2013), 402–406.
146. Tian, X.L., Li, Y., Endothelial cell senescence and age related vascular diseases. J. Genet. Genom. 41:9 (2014), 485–495.
147. Tostes, R.C., Carneiro, F.S., Carvalho, M.H., Reckelhoff, J.F., Reactive oxygen species: players in the cardiovascular effects of testosterone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310:1 (2016), R1–R14.
148. Tousoulis, D., Andreou, I., Antoniades, C., Tentolouris, C., Stefanadis, C., Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 201:2 (2008), 236–247.
149. Tousoulis, D., Andreou, I., Tsiatas, M., Miliou, A., Tentolouris, C., Siasos, G., Papageorgiou, N., Papadimitriou, C.A., Dimopoulos, M.A., Stefanadis, C., Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress. Atherosclerosis 214 (2011), 151–157.
150. Turgeon, J., Dussault, S., Maingrette, F., Groleau, J., Haddad, P., Perez, G., Rivard, A., Fish oil-enriched diet protects against ischemia by improving angiogenesis, endothelial progenitor cell function and postnatal neovascularization. Atherosclerosis 229:2 (2013), 295–303.
151. Van Craenenbroeck, E.M., Bruyndonckx, L., Van Berckelaer, C., Hoymans, V.Y., Vrints, C.J., Conraads, V.M., The effect of acute exercise on endothelial progenitor cells is attenuated in chronic heart failure. Eur. J. Appl. Physiol. 111:9 (2011), 2375–2379.
152. Vasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A.M., Dimmeler, S., Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 24 (2001), 2885–2890.
153. Volaklis, K.A., Tokmakidis, S.P., Halle, M., Acute and chronic effects of exercise on circulating endothelial progenitor cells in healthy and diseased patients. Clin. Res. Cardiol. 102:4 (2013), 249–257.
154. Walther, C., Adams, V., Bothur, I., Drechsler, K., Fikenzer, S., Sonnabend, M., Bublitz, B., Körner, A., Erbs, S., Busse, M., Schuler, G., Increasing physical education in high school students: effects on concentration of circulating endothelial progenitor cells. Eur. J. Cardiovasc. Prev. Rehabil. 15:4 (2008), 416–422.
155. Walther, C., Gaede, L., Adams, V., Gelbrich, G., Leichtle, A., Erbs, S., Sonnabend, M., Fikenzer, K., Körner, A., Kiess, W., Bruegel, M., Thiery, J., Schuler, G., Effect of increased exercise in school children on physical fitness and endothelial progenitor cells: a prospective randomized trial. Circulation 120:22 (2009), 2251–2259.
156. Wang, C.H., Ting, M.K., Verma, S., Kuo, L.T., Yang, N.I., Hsieh, I.C., Wang, S.Y., Hung, A., Cherng, W.J., Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am. Heart J., 152, 2006, 1051.
157. Wang, J.S., Lee, M.Y., Lien, H.Y., Weng, T.P., Hypoxic exercise training improves cardiac/muscular hemodynamics and is associated with modulated circulating progenitor cells in sedentary men. Int. J. Cardiol. 170:3 (2014), 315–323.
158. Werner, C., Baumhäkel, M., Teo, K.K., Schmieder, R., Mann, J., Unger, T., Yusuf, S., Böhm, M., RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clin. Res. Cardiol. 97:7 (2008), 418–431.
159. Werner, C., Kamani, C.H., Gensch, C., Böhm, M., Laufs, U., The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 56 (2007), 2609–2615.
160. Westerweel, P.E., Visseren, F.L., Hajer, G.R., Olijhoek, J.K., Hoefer, I.E., de Bree, P., Rafii, S., Doevendans, P.A., Verhaar, M.C., Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur. Heart J. 29:22 (2008), 2808–2817.
161. Wojakowski, W., Pyrlik, A., Król, M., Buszman, P., Ochała, A., Milewski, K., Smolka, G., Kawecki, D., Rudnik, A., Pawłowski, T., Jadczyk, T., Wyderka, R., Cybulski, W., Dworowy, S., Tendera, M., Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). Minerva Cardioangiol. 61:3 (2013), 301–311.
162. Wolk, R., Deb, A., Caplice, N.M., Somers, V.K., Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 183:1 (2005), 131–139.
163. Xiao-Yun, X., Zhao-Hui, M., Ke, C., Hong-Hui, H., Yan-Hong, X., Glucagon-like peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation. Med. Sci. Monit. 17:2 (2011), BR35–BR41.
164. Xu, J., Zou, M.H., Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 120:13 (2009), 1266–1286.
165. Ye, H., He, F., Fei, X., Lou, Y., Wang, S., Yang, R., Hu, Y., Chen, X., High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period. J. Cardiovasc. Pharmacol. Ther. 19:3 (2014), 290–295.
166. Yip, H.K., Tsai, T.H., Lin, H.S., Chen, S.F., Sun, C.K., Leu, S., Yuen, C.M., Tan, T.Y., Lan, M.Y., Liou, C.W., Lu, C.H., Chang, W.N., Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Crit. Care, 15(1), 2011, R40.
167. Yoshida, O., Kondo, T., Kureishi-Bando, Y., Sugiura, T., Maeda, K., Okumura, K., Murohara, T., Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers. Circ. J. 74:1 (2010), 195–202.
168. Youn, S.W., Lee, S.W., Lee, J., Jeong, H.K., Suh, J.W., Yoon, C.H., Kang, H.J., Kim, H.Z., Koh, G.Y., Oh, B.H., Park, Y.B., Kim, H.S., COMP-Ang1 stimulates HIF-1α-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. Blood 117:16 (2011), 4376–4386.
169. Zampetaki, A., Kirton, J.P., Xu, Q., Vascular repair by endothelial progenitor cells. Cardiovasc. Res. 78:3 (2008), 413–421.
170. Zhang, L., Xu, Q., Stem/progenitor cells in vascular regeneration. Arterioscler. Thromb. Vasc. Biol. 34:6 (2014), 1114–1119.
171. Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O.E., Woerle, H.J., Broedl, U.C., Inzucchi, S.E., EMPA-REG OUTCOME Investigators, Empagliflozin cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373:November (22) (2015), 2117–2128.